Diversified Consumer Services
Company Overview of University of Oxford
University of Oxford is an educational institution that provides undergraduate, graduate, research, and distance learning programs. It offers courses in humanities; physical and life sciences; medical sciences; mathematics; social sciences; archaeology and anthropology; biological sciences; biochemistry; chemistry; and economics and management. The university was founded in 1096 and is based in Oxford, United Kingdom.
Oxford, OX1 2JD
Founded in 1096
Key Executives for University of Oxford
President of Kellogg College at Oxford University and Director of the Department for Continuing Education
Compensation as of Fiscal Year 2015.
University of Oxford Key Developments
University of Oxford Presents at African Mining Indaba 2016, Feb-10-2016 10:00 AM
Feb 5 16
University of Oxford Presents at African Mining Indaba 2016, Feb-10-2016 10:00 AM. Venue: Cape Town, South Africa. Speakers: Paul Collier, Professor of Economics and Public Policy, Blavatnik School of Government.
University of Oxford Presents at Cayman Alternative Investment Summit 2016, Feb-04-2016
Dec 14 15
University of Oxford Presents at Cayman Alternative Investment Summit 2016, Feb-04-2016 . Venue: Cayman Islands. Speakers: Tarun Ramadorai, Professor of Financial Economics, Saïd Business School.
C4X Discovery Holdings plc Enters Research Collaboration with University of Oxford
Dec 11 15
C4X Discovery Holdings plc, or C4XD has entered into a research collaboration with the University of Oxford's Structural Genomics Consortium department, or SGC-Oxford. SGC-Oxford is part of the Nuffield Department of Clinical Medicine and consists of around 100 scientists who collaborate widely with major pharmaceutical companies and the worldwide academic network, including several other University Departments, such as the Kennedy Institute of Rheumatology, the Botnar Research Centre and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS). These scientists combine world-class expertise in therapeutic target validation, protein expression, assay development and protein structural information. Under the terms of the collaboration announced that, C4XD will be granted access to structural, biological and therapeutic information that SGC-Oxford holds in relation to various therapeutic targets and related assays, as well as initial 'hit' molecules that SGC-Oxford has identified against these targets. C4XD's expertise in ligand design will be used to complement SGC-Oxford's expertise in x-ray crystallography, screening and chemical biology in the identification of new and improved hit molecules against the SGC-Oxford targets. Improvements made to SGC-Oxford's existing hit molecules will be the exclusive property of SGC-Oxford, which will make them freely available in line with SGC-Oxford policy, while new compounds independently identified by C4XD will belong to C4XD.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|